Recent advances in the treatment of chronic heart failure

After more than a decade of relatively modest advancements, heart failure therapeutic development has accelerated, with the PARADIGM-HF trial and the SHIFT trial demonstrated significant reductions in cardiovascular death and heart failure hospitalization for sacubitril-valsartan and in heart failur...

Descripción completa

Detalles Bibliográficos
Autores principales: Buckley, Leo F, Shah, Amil M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944255/
https://www.ncbi.nlm.nih.gov/pubmed/31942237
http://dx.doi.org/10.12688/f1000research.20447.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944255/
https://www.ncbi.nlm.nih.gov/pubmed/31942237
http://dx.doi.org/10.12688/f1000research.20447.1

Ejemplares similares